Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results
Wednesday, December 11 2024 | 10 h 01 min | News
A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet...
Read More
Canada’s Vision Health Stakeholders Applaud Parliament’s Passage of Bill C-284, the National Strategy for Eye Care Act
Monday, November 18 2024 | 14 h 57 min | News
The recent passage of Bill C-284, the National Strategy for Eye Care Act by the Government of Canada, marks a significant advancement in the...
Read More
Robotic Radiation Treatment May Help Treat Wet AMD
Wednesday, October 16 2024 | 13 h 46 min | Vision Science
A new study, published in The Lancet, suggests that a one-time radiation therapy may reduce the number of anti-VEGF injections needed for wet...
Read More First Patients Treated in XLRP Gene Therapy Trial
Tuesday, September 17 2024 | 14 h 31 min | Vision Science
Beacon Therapeutics, has announced that they have treated the first patients in their Phase 2/3 VISTA trial for a gene therapy for X-linked...
Read More
New Gene Replacement Clinical Trial Launched for RP Test
Tuesday, September 3 2024 | 08 h 46 min | Vision Science & Research
ViGeneron in Munich, Germany has launched a new Phase 1b clinical trial testing a novel gene replacement therapy in individuals affected by...
Read More
